Visits: 2105, Avg visit time (secs): 261,19 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 1375 | 65,32% | |
| /programmes.html | 101 | 4,80% |
| /msd/basic/efsd-msd-basic-rfa09.html | 75 | 3,56% |
| /dcure/efsd-dcure-rfa08.html | 52 | 2,47% |
| /regulations.html | 39 | 1,85% |
| /novartis/efsd-novartis-rfa09.html | 34 | 1,62% |
| /msd/clinical/efsd-msd-clinical-rfa09.html | 33 | 1,57% |
| /new_horizons/new-horizons09.html | 27 | 1,28% |
| /msd/albert-renold/efsd-msd-arenold.html | 24 | 1,14% |
| /home.html | 24 | 1,14% |
| /amylin/efsd-amylin-rfa09.html | 19 | 0,90% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 1371 | 65,13% |
| /new_horizons/new-horizons09.html | 154 | 7,32% |
| /dcure/efsd-dcure-rfa08.html | 52 | 2,47% |
| /home.html | 39 | 1,85% |
| /programmes.html | 35 | 1,66% |
| /lilly/fellowships/efsd-lilly-fship09.html | 32 | 1,52% |
| /efsd-grant/efsd-clinresgrant-rfa08.html | 26 | 1,24% |
| /msd/basic/efsd-msd-basic-rfa09.html | 20 | 0,95% |
| /recipients.html | 18 | 0,86% |
| /gsk/efsd-gsk-rfa08.html | 16 | 0,76% |
| /msd/albert-renold/efsd-msd-arenold.html | 16 | 0,76% |